NASDAQ:GUTS Fractyl Health Q3 2026 Earnings Date & Estimates $0.93 +0.03 (+3.80%) Closing price 11/6/2026 04:00 PM EasternExtended Trading$0.94 +0.01 (+0.56%) As of 11/6/2026 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Fractyl Health is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 12, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Fractyl Health in Q3 2026Fractyl Health is expected to post earnings of -$1.59 per share. In the same quarter a year earlier Fractyl Health reported -$4.20 per share. Fractyl Health last reported on August 10, 2026, posting -$1.44 per share and beating the -$1.62 consensus estimate. Fractyl Health has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$1.59Prior-Year EPS-$4.20Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$1.44 (Beat by +$0.18)EPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Fractyl Health Q3 2026 Earnings FAQ When does Fractyl Health report Q3 2026 earnings? Fractyl Health (NASDAQ:GUTS) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Fractyl Health's Q3 2026 earnings call? Fractyl Health's Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Fractyl Health? Analysts expect Fractyl Health to post earnings of -$1.59 per share for Q3 2026. Fractyl Health Earnings HeadlinesFractyl Health, Inc. (GUTS) AI Stock AnalysisNovember 6 at 8:30 PM | tipranks.comFractyl Health Appoints Michael Wartell to BoardNovember 6 at 5:11 PM | tipranks.comMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.November 8 at 1:00 AM | Porter & Company (Ad)Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026November 6 at 7:00 AM | globenewswire.comFractyl Health (GUTS) Stock Fair Value Falls After Mixed Revita Analyst ReactionsNovember 5 at 6:30 PM | finance.yahoo.comFractyl Health Announces Additions To Revita Patent Portfolio As It Advances Toward FDA Submission And Potential CommercializationOctober 31, 2026 | marketscreener.comMSee More Fractyl Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fractyl Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fractyl Health and other key companies, straight to your email. Email Address About Fractyl HealthFractyl Health (NASDAQ:GUTS) is a biotechnology company focused on developing therapies for metabolic diseases, including obesity and type 2 diabetes. The company aims to create treatments that address the underlying biology of these conditions and provide longer-lasting alternatives to frequently administered medicines. Fractyl Health’s technology platforms include Revita, an endoscopic procedure designed to modify the lining of the duodenum and potentially improve metabolic function, and a gene therapy platform intended to enable the body to produce therapeutic levels of metabolic hormones such as glucagon-like peptide-1 (GLP-1). The company is advancing these approaches through research and clinical development programs. Founded in 2011, Fractyl Health is headquartered in Lexington, Massachusetts, and develops its programs for potential use in major global markets. The company is led by co-founder and Chief Executive Officer Harith Rajagopalan, M.D., Ph.D.View Fractyl Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/2 - 11/6IonQ's Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?The Ugly Truth Behind SoundHound’s Q3 ResultsSandisk Shares Are Oversold: Bargain or Value Trap?Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater? Upcoming Earnings Occidental Petroleum (11/9/2026)KKR & Co. Inc. (11/9/2026)Barrick Mining (11/9/2026)Constellation Energy (11/9/2026)Petroleo Brasileiro S.A.- Petrobras (11/10/2026)Transdigm Group (11/10/2026)Honda Motor (11/11/2026)Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
